WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997013760) TRICYCLIC FUSED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/013760    International Application No.:    PCT/EP1996/004396
Publication Date: 17.04.1997 International Filing Date: 10.10.1996
Chapter 2 Demand Filed:    23.04.1997    
IPC:
C07D 239/70 (2006.01), C07D 495/04 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (For All Designated States Except US).
McKEOWN, Stephen, Carl [GB/GB]; (GB) (For US Only).
PAGE, Martin, John [GB/GB]; (GB) (For US Only).
VILE, Sadie [GB/GB]; (GB) (For US Only).
WALKER, Ann, Louise [GB/GB]; (GB) (For US Only).
HUDSON, Alan, Thomas [GB/GB]; (GB) (For US Only).
BARRACLOUGH, Paul [GB/GB]; (GB) (For US Only).
FRANZMANN, Karl, Witold [GB/GB]; (GB) (For US Only)
Inventors: McKEOWN, Stephen, Carl; (GB).
PAGE, Martin, John; (GB).
VILE, Sadie; (GB).
WALKER, Ann, Louise; (GB).
HUDSON, Alan, Thomas; (GB).
BARRACLOUGH, Paul; (GB).
FRANZMANN, Karl, Witold; (GB)
Agent: REED, Michael, A.; Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB)
Priority Data:
9520822.9 11.10.1995 GB
Title (EN) TRICYCLIC FUSED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
(FR) COMPOSES CONDENSES TRICYCLIQUES ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
Abstract: front page image
(EN)Substituted heteroaromatic compounds, in particular substituted tricyclic fused compounds in which one terminal ring is pyridine or pyrimidine, are protein tyrosine kinase inhibitors. The compounds are described as are methods for their preparation, pharmaceutical compositions including such compounds and their use in medicine, for example in the treatment of psoriasis, fibrosis, atherosclerosis, restenosis, auto-immune disease, allergy, asthma, transplantation rejection, inflammation, thrombosis, nervous system diseases, and cancer.
(FR)Les composés hétéroaromatiques substitués, en particulier les composés condensés tricycliques substitués dans lequel un noyau terminal est une pyridine ou une pyrimidine, constituent des inhibiteurs de la tyrosine kinase. On décrit de tels composés ainsi des procédés permettant de les préparer, des compositions pharmaceutiques contenant ces composés et leur utilisation en médecine, par exemple pour traiter: psoriasis, fibrose, athérosclérose, resténose, maladies auto-immunes, allergies, asthme, rejet de greffon, inflammations, thrombose, maladies du système nerveux et cancer.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)